Inflammation in Intrahepatic Cholestasis of Pregnancy
Status: Recruiting
Location: See all (11) locations...
Study Type: Observational
SUMMARY
This observational prospective study will help to determine if an immune process similar to allograft rejection is responsible for the occurrence of an intrahepatic cholestasis of pregnancy (ICP). If so, it would suggest the potential benefit of immunomodulatory therapeutics.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:
• Adult pregnant woman with singleton
⁃ For cases: diagnosis of intrahepatic cholestasis of pregnancy For controls: no diagnosis of ICP
Locations
Other Locations
France
CHU Angers
NOT_YET_RECRUITING
Angers
CHU de Brest
RECRUITING
Brest
Polyclinique KERAUDREN
RECRUITING
Brest
CHU de Caen
RECRUITING
Caen
CH de Chambery
RECRUITING
Chambéry
CH Bretagne Sud
RECRUITING
Lorient
CHU Nantes
RECRUITING
Nantes
CH de Quimper
RECRUITING
Quimper
CHU de Rennes
RECRUITING
Rennes
CH St Brieuc
RECRUITING
Saint-brieuc
CHU de Tours
RECRUITING
Tours
Contact Information
Primary
Claire de Moreuil
claire.demoreuil@chu-brest.fr
02 98 14 53 03
Backup
Philippe Merviel
philippe.merviel@chu-brest.fr
02-98-22-39-70
Time Frame
Start Date: 2022-06-21
Estimated Completion Date: 2025-06-22
Participants
Target number of participants: 322
Treatments
Cases
Women with intrahepatic cholestasis of pregnancy
Controls
Women without intrahepatic cholestasis of pregnancy
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Brest